NCT05958511|Unknown
Loading search results
Sponsor study identifier
observational
130
0 countries
N/A
Study Start
September 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
June 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The many comorbidities in the severely ill patient also make thrombocytopenia very common (∼ 40%) in intensive care unit patients. The risk of bleeding is high with severe thrombocytopenia and is enhanced in intensive care patients with mild or moderately low platelet counts when additional factors are present that interfere with normal hemostatic mechanisms (eg, platelet function defects, hyperfibrinolysis, invasive procedures, or catheters).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 15, 2023
Actual (reported)July 24, 2023
Actual (reported)September 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Identify the prevalence thrombocytopenia.
The study is aimed to identify the prevalence of thrombocytopenia in patients admitted to pediatric intensive care unit.
Baseline
Identify the risk factors of thrombocytopenia
The study is aimed to identify the risk factors of thrombocytopenia in patients admitted to pediatric intensive care unit.
Baseline
Identify the outcome of thrombocytopenia
The study is aimed to identify the outcome of thrombocytopenia in patients admitted to pediatric intensive care unit.
Baseline
130 Children and infants aged one month to 18 years admitted to the ICU in period from August 2023 to August 2024 and developed thrombocytopenia documented in laboratory investigation done in PICU.
First Submitted
July 15, 2023
First Posted
July 24, 2023
Study Start
September 1, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
June 1, 2024
Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 24, 2023
Record last verified: 2023-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: